Lantern Pharma Inc (LTRN)

The artificial intelligence (AI) boom is far from over. For example let's look at Nvidia (NASDAQ:NVDA), where CEO Jensen Huang still believes his stock is…

The 3 Most Undervalued Machine Learning Stocks to Buy Now: August 2023

By Matthew Farley, InvestorPlace Contributor Aug 23, 2023

Machine learning stocks still have a lot of room left to rise despite a short-term pullback in their stock prices.

The 3 Most Undervalued AI Penny Stocks to Buy Now: August 2023

By Ian Cooper, InvestorPlace Contributor Aug 16, 2023

Not only would I take full advantage of the pullbacks in heavyweight AI stocks, I’d also take advantage of the drops in top AI penny stocks.

3 AI Penny Stocks With the Potential to Make Your Financial Dreams Come True

By Muslim Farooque, InvestorPlace Contributor Aug 9, 2023

These top three AI penny stocks offer immense upside ahead, potentially becoming future market leaders amid a $15.7 trillion projection.

3 AI Stocks You’ll Regret Not Buying Soon

By Ian Cooper, InvestorPlace Contributor Aug 8, 2023

AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in.

7 AI Stocks to Buy Under $5 in August 2023

By Alex Sirois, InvestorPlace Contributor Aug 2, 2023

These AI stocks to buy for under $5 in August have strong potential as the sector grows throughout 2023 and beyond

3 AI Stocks to Buy Under $10 in August 2023

By Ian Cooper, InvestorPlace Contributor Aug 1, 2023

The bull market in artificial intelligence is just getting started, creating big opportunity for this list of AI stocks under $10.

7 AI Penny Stocks that Could Hit $5 Soon

By Chris Markoch, InvestorPlace Contributor Jul 30, 2023

Here are seven AI penny stocks with huge potential as you look to make life-changing money from the advance of artificial intelligence

3 Penny Stocks to Buy as the AI Sector Transforms Every Industry in 2023

By Muslim Farooque, InvestorPlace Contributor May 19, 2023

These AI penny stocks could potentially offer potent long-term value at tremendously attractive prices at this time

7 AI Penny Stocks That Could Skyrocket in 2023

By Alex Sirois, InvestorPlace Contributor Feb 21, 2023

AI penny stocks represent great potential and high returns, given the fact this technology is only beginning to pervade society.

8 Best Artificial Intelligence Stocks Under $10

From MarketBeat Aug 18, 2023

If you want to get in on artificial intelligence (AI) but don’t want to spend a lot, why not consider artificial intelligence stocks under $10? Learn more.

Lantern Pharma gets FDA clearance to begin P1 testing for LP-184 (LTRN)

From Seeking Alpha Jun 12, 2023

Lantern Pharma (LTRN) said the FDA has cleared the company to begin Phase 1 testing of its drug candidate LP-184 for the treatment of solid cancerous tumors. Read more here.

Lantern forms unit Starlight focused on CNS disorders, brain cancers

From Seeking Alpha Mar 6, 2023

Lantern Pharma (LTRN) said it has formed a wholly-owned subsidiary called Starlight Therapeutics to focus exclusively on developing therapies for central nervous system ((CNS)) and...

FDA grants orphan drug designation to Lantern Pharma's (NASDAQ:LTRN) LP-284

From Seeking Alpha Jan 5, 2023

Lantern Pharma (LTRN) said the U.S. FDA had granted an orphan drug designation to its LP-284 candidate for the treatment of mantle cell lymphoma. Read more here.

Lantern Pharma: Q4 Earnings Insights

From Benzinga Mar 10, 2022

Lantern Pharma (NASDAQ:LTRN) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...

Earnings Outlook For Lantern Pharma

From Benzinga Mar 9, 2022

Lantern Pharma (NASDAQ:LTRN) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement. Analysts...

Lantern Pharma Inc (LTRN)

LTRN Stock Earnings: Lantern Pharma Misses EPS for Q1 2024

3 Machine Learning Stocks with the Potential to Make You an Overnight Millionaire

LTRN Stock Earnings: Lantern Pharma Beats EPS for Q4 2023

3 AI Powerhouses Predicted to Soar 500% in the Next Tech Boom

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Lantern Pharma Inc (LTRN)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

LTRN Stock Predictions, Articles, and Lantern Pharma Inc News

Subscriber Sign in